Works matching IS 14248247 AND DT 2012 AND VI 5 AND IP 1
Results: 6
DNA Methylation as Clinically Useful Biomarkers—Light at the End of the Tunnel.
- Published in:
- Pharmaceuticals (14248247), 2012, v. 5, n. 1, p. 94, doi. 10.3390/ph5010094
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors.
- Published in:
- Pharmaceuticals (14248247), 2012, v. 5, n. 1, p. 79, doi. 10.3390/ph5010079
- By:
- Publication type:
- Article
Potential Use of Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for siRNA.
- Published in:
- Pharmaceuticals (14248247), 2012, v. 5, n. 1, p. 61, doi. 10.3390/ph5010061
- By:
- Publication type:
- Article
Anti-HCV RNA Aptamers Targeting the Genomic cis-Acting Replication Element.
- Published in:
- Pharmaceuticals (14248247), 2012, v. 5, n. 1, p. 49, doi. 10.3390/ph5010049
- By:
- Publication type:
- Article
New Strategies to Develop Novel Pain Therapies: Addressing Thermoreceptors from Different Points of View.
- Published in:
- Pharmaceuticals (14248247), 2012, v. 5, n. 1, p. 16, doi. 10.3390/ph5010016
- By:
- Publication type:
- Article
Pre-Clinical Assessment of <sup>177</sup>Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease.
- Published in:
- Pharmaceuticals (14248247), 2012, v. 5, n. 1, p. 1, doi. 10.3390/ph5010001
- By:
- Publication type:
- Article